Last well person: How to stay well despite the health-care system

Last Well Person: How to Stay Well Despite the Health-Care System

Volumn , Issue , 2007, Pages 1-313

  Hadler, Nortin M ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84897174642     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Book

References (495)

1. Ackerknecht EH. Rudolf Virchow. Madison: University of Wisconsin Press, 1953.
2. Adachi M, Saito H, Kobayashi H, et al. Hepatic injury in 12 patients taking the herbal weight loss aids chaso or onshido. Ann Intern Med 2003; 139: 488-92.
3. Adler AI, Stratton IM, Andrew H, et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (ukpds 36): prospective observational study. BMJ 2000; 321: 412-9.
4. AHRQ. Osteoporosis in Postmenopausal Women: Diagnosis and Monitoring. Summary. Evidence Report/Technology Assessment: Number 28: AHRQ Publication 01-E031; February 2001. Rockville, md. Agency for Healthcare Research and Quality; www.ahrq.gov/clinic/osteosum.htm.
5. Albright F, Smith PH, Richardson AM. Menopausal osteoporosis. JAMA 1941; 22: 2465-74.
6. Alderson P, Chalmers I. Survey of claims of no effect in abstracts of Cochrane reviews. BMJ 2003; 326: 475.
7. ALLHAT. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. JAMA 2002; 288: 2981-97.
8. ALLHAT-LLT. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care. JAMA 2002; 288: 2998-3007.
9. Als-Nielsen B, Chen W, Gluud C, Kjaergard LL. Association of funding and conclusions in randomized drug trials. JAMA 2003; 290: 921-8.
10. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. Arthritis Rheum 2000; 45: 1905-15.
11. Andersen LB, Schnohr P, Schroll M, Hein HO. All-cause mortality associated with physical activity during leisure time, work, sports, and cycling to work. Arch Intern Med 2000; 160: 1621-8.
12. Anderson GL, Judd HL, Kaunitz AM, et al. Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures. JAMA 2003; 290: 1739-48.
13. Andersson GBJ, Lucente T, Davis AM, et al. A comparison of osteopathic spinal manipulation with standard care for patients with low back pain. N Engl J Med 1999; 341: 1426-31.
14. Angell M. Is academic medicine for sale? N Engl J Med 2000; 342: 1516-8.
15. Angell M. The pharmaceutical industry-to whom is it accountable? N Engl J Med 2000; 342: 1902-4.
16. Ang-Lee MK, Moss J, Yuan C-S. Herbal medicines and perioperative care. JAMA 2001; 286: 208-16.
17. Appel LJ, Moore TJ, Obarzanek E, et al. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med 1997; 336: 1117-24.
18. Applegate WB, Pressel S, Wittes J, et al. Impact of the treatment of isolated systolic hypertension on behavioral variables: results from the Systolic Hypertension in the Elderly Program. Arch Intern Med 1994; 154: 2154-60.
19. Ascherio A, Rimm EB, Hernán MA, et al. Relation of consumption of vitamin E, vitamin C, and carotenoids to risk for stroke among men in the United States. Ann Intern Med 1999; 130: 963-70.
20. Ascherio A, Rimm EB, Stampfer MJ, et al. Dietary intake of marine n-3 fatty acids, fish intake and the risk of coronary artery disease among men. N Engl J Med 1995; 332: 977-82.
21. Assenfeldt WJJ, Morton SC, Yu EI, Suttorp MJ, Shekelle PG. Spinal manipulative therapy for low back pain. Ann Intern Med 2003; 138: 871-81.
22. Astin JA. Why patients use alternative medicine. JAMA 1998; 279: 1548-53.
23. Astin JA, Harkness E, Ernst E. The efficacy of "distant healing": a systematic review of randomized trials. Ann Intern Med 2000; 132: 903-10.
24. ATBC Group. Incidence of cancer and mortality following α-tocopherol and β-carotene supplementation. JAMA 2003; 290: 476-85.
25. Atkin PA. A paradigm shift in the medical literature. BMJ 2002; 325: 1450-1.
26. Babcock LJ, Lewis M, Hay EM, et al. Chronic shoulder pain in the community: a syndrome of disability or distress? Ann Rheum Dis 2002; 61: 128-31.
27. Baigent C, Patrono C. Selective cyclooxygenase 2 inhibitors, aspirin, and cardiovascular disease. Arthritis Rheum 2003; 48: 12-20.
28. Baines CJ. The Canadian National Breast Screening Study: a perspective on criticisms. Ann Intern Med 1994; 120: 326-34.
29. Baker KR, Nelson ME, Felson DT, et al. The efficacy of home based progressive strength training in older adults with knee osteoarthritis: a randomized controlled trial. J Rheumatol 2001; 28: 1655-65.
30. Baker T. On the genealogy of moral hazard. Texas Law Review 1996; 75: 237-92.
31. Baron JA, Cole BF, Sandler RS, et al. A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med 2003; 348: 891-9.
32. Barr RG, Nathan DM, Meigs JB, Singer DE. Tests of glycemia for the diagnosis of type 2 diabetes mellitus. Ann Intern Med 2002; 137: 263-72.
33. Barrett BP, Brown RL, Locken K, et al. Treatment of the common cold with unrefined echinacea. Ann Intern Med 2002; 137: 939-46.
34. Barrett-Connor E, Grady D, Sashegyi A, et al. Raloxifene and cardiovascular events in osteoporotic postmenopausal women. JAMA 2002; 287: 847-57.
35. Barringer TA, Kirk JK, Santaniello AC, Foley KL, Michielutte R. Effect of a multivitamin and mineral supplement on infection and quality of life. Ann Intern Med 2003; 138: 365-71.
36. Barsky AJ. The patient with hypochondriasis. N Engl J Med 2001; 345: 1395-9.
37. Barsky AJ, Borus JF. Functional somatic syndromes. Ann Intern Med 1999; 130: 910-21.
38. Bates DW, Black DM, Cummings SR. Clinical use of bone densitometry: clinical applications. JAMA 2002; 288: 1898-900.
39. Beckles GLA, Thompson-Reid PE. Socioeconomic status of women with diabetes-United States, 2000. MMWR 2002; 51: 147-59.
40. Bekelman JE, Li Y, Gross CP. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA 2003; 289: 454-65.
41. Benjamin S, Morris S, McBeth J, et al. The association between chronic widespread pain and mental disorder. Arthritis Rheum 2000; 43: 561-7.
42. Bergman S, Herrström P, Jacobsson LTH, Petersson IF. Chronic widespread pain: a three year followup of pain distribution and risk factors. J Rheumatol 2002; 29: 818-25.
43. Berkman L, Kawachi I, eds. Social Epidemiology. Oxford: Oxford University Press, 2000.
44. Benson K, Hartz AJ. A comparison of observational studies and randomized controlled trials. N Engl J Med 2000; 342: 1878-86.
45. Berlin JA, Rennie D. Measuring the quality of trials. JAMA 1999; 282: 1083-5.
46. Bialar JC, Gornik HL. Cancer undefeated. N Engl J Med 1997; 336: 1569-74.
47. Bigger JT. Diuretic therapy, hypertension, and cardiac arrest. N Engl J Med 1994; 330: 1899-1900.
48. Bigos SJ, Bowyer OR, Braen GR, et al. Acute Low Back Problems in Adults. US Department of Health and Human Services, ahcpr Publ. No. 95-0642, 1994.
49. Billroth T. The Medical Sciences in the German Universities: A Study in the History of Civilization. New York: Macmillan, 1924.
50. Black DM, Cummings SR, Karpf DB, et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 1996; 348: 1535-41.
51. Blackmore S. The Meme Machine. Oxford: Oxford University Press, 1999.
52. Bodenheimer T. Uneasy alliance: clinical investigators and the pharmaceutical industry. N Engl J Med 2000; 342: 1539-43.
53. Bombardier C, Laine L, Reicin A, et al. Comparison of upper gastrointestinal toxicity of refecoxib and naproxen in patients with rheumatoid arthritis. N Engl J Med 2000; 343: 1520-8.
54. Bonadonna G, Valagussa P, Moliterni A, et al. Adjuvant cyclophosphamide, methotrexate and fluorouracil in node-positive breast cancer. N Engl J Med 1995; 332: 901-6.
55. Borg V, Kristensen TS, Burr H. Work environment and changes in selfrated health: a five year follow-up study. Stress Med 2000; 16: 37-47.
56. Bosma H, Peter R, Siegrist J, Marmot M. Two alternative job stress models and risk of coronary heart disease. Am J Public Health 1998; 88: 68-74.
57. Boutitie F, Gueyffier F, Pocock S, et al. J-shaped relationship between blood pressure and mortality in hypertensive patients: new insights from a meta-analysis of individual-patient data. Ann Intern Med 2002; 136: 438-48.
58. Boyd NF, Dite GS, Stone J, et al. Heritability of mammographic density, a risk factor for breast cancer. N Engl J Med 2002; 347: 886-94.
59. Bracken P, Thomas P. Time to move beyond the mind-body split. BMJ 2002; 325: 1433-4.
60. Brancati FL, Kao WHL, Folsom AR, et al. Incident type 1 diabetes mellitus in African American and white adults. JAMA 2000; 283: 2253-9.
61. Brandt KD, Bradley JD. Should the initial drug used to treat osteoarthritis pain be a nonsteroidal anti-inflammatory drug? J Rheumatol 2001; 28: 467-73.
62. Brandt KD, Heilman DK, Slemenda C, et al. A comparison of lower extremity muscle strength, obesity, and depression scores in elderly subjects with knee pain with and without radiographic evidence of knee osteoarthritis. J Rheumatol 2000; 27: 1937-46.
63. Bressler HB, Keyes WJ, Rochon PA, Badley E. The prevalence of low back pain in the elderly. Spine 1999; 24: 1813-9.
64. Brett AS. Psychologic effects of the diagnosis and treatment of hypercholesterolemia: lessons from case studies. Am J Med 1991; 91: 642-7.
65. Bronfort G. Spinal manipulation: current state of research and its indications. Neurol Clin 1999; 17: 91-111.
66. Brosseau L, Milne S, Robinson V, et al. Efficacy of the transcutaneous electrical nerve stimulation for the treatment of chronic low back pain. Spine 2002; 27: 596-603.
67. Bruyere O, Honore A, Rovati LC, et al. Radiologic features poorly predict clinical outcomes in knee osteoarthritis. Scand J Rheumatol 2002; 31: 13-6.
68. Cannon WB. The Wisdom of the Body. New York: WW Norton, 1932.
69. Carey TS, Garrett J, Jackman A, et al. The outcomes and costs of care for acute low back pain among patients seen by primary care practitioners, chiropractors and orthopedic surgeons. N Engl J Med 1995; 333: 913-7.
70. Caro J, Klittich W, McGuire A, et al. The West of Scotland coronary prevention study: economic benefit analysis of primary prevention with pravastatin. BMJ 1997; 315: 1577-82.
71. CASS Principal Investigators. Myocardial infarction and mortality in the coronary artery surgery study (cass) randomized trial. N Engl J Med 1984; 310: 750-8.
72. Cauley JA, Robbins J, Chen Z, et al. Effects of estrogen plus progestin on risk of fracture and bone mineral density. JAMA 2003; 290: 1729-38.
73. Chapple A, Ziebland S, Shepperd S, et al. Why men with prostate cancer want wider access to prostate specific antigen testing: qualitative study. BMJ 2002; 325: 737-9.
74. Chapuy MC, Arlot ME, Duboeuf F, et al. Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl J Med 1992; 327: 1637-42.
75. Cheng Y, Kawachi I, Coakley EH, et al. Association between psychosocial work characteristics and health functioning in American women: prospective study. BMJ 2000; 320: 1432-6.
76. Cherkin DC, Sherman KJ, Deyo RA, Shekelle PG. A review of the evidence for the effectiveness, safety, and cost of acupuncture, massage therapy, and spinal manipulation for back pain. Ann Intern Med 2003; 138: 898-906.
77. Chlebowski RT, Hendrix SL, Langer RD, et al. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women. JAMA 2003; 290: 3243-53.
78. Chren M-M, Landefeld S. Physicians' behavior and their interactions with drug companies. JAMA 1994; 271: 684-9.
79. Cohen L. No Aging in India. Berkeley: University of California Press, 1998.
80. Collacott EA, Zimmerman JT, White DW, Rindone JP. Bipolar permanent magnets for the treatment of chronic low back pain. JAMA 2000; 283: 1322-5.
81. Cooper RS, Kaufman JS, Ward R. Race and genomics. N Engl J Med 2003; 348: 1166-70.
82. Cope O. Man, Mind & Medicine. Philadelphia: Lippincott, 1968.
83. Coulehan JL. The treatment act: an analysis of the clinical art in chiropractic. J Manipulative Physiol Ther 1991; 14: 5-13.
84. Coulter ID, Hurwitz EL, Adams AH, et al. Patients using chiropractors in North America. Spine 2002; 27: 291-8.
85. Cranney A, Welch V, Adachi JD, et al. Etidronate for treating and preventing postmenopausal osteoporosis. Cochrane Database Syst Rev 2001; (4): CD003376 (25 March 2001).
86. Cree M, Solkolne CL, Belseck E, et al. Mortality and institutionalization following hip fracture. J Am Geriatr Soc 2000; 48: 283-8.
87. Croft P. Testing for tenderness: what's the point? J Rheumatol 2000; 27: 2531-3.
88. Cummings SR, Bates DB, Black DM. Clinical use of bone densitometry: scientific review. JAMA 2002; 288: 1889-97.
89. Cummings SR, Black DM, Thompson DE, et al. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures. JAMA 1998; 280: 2077-82.
90. Curb JD, Pressel SL, Cutler JA, et al. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. JAMA 1996; 276: 1886-92.
91. Dana J, Loewenstein G. A social science perspective on gifts to physicians from industry. JAMA 2003; 290: 252-5.
92. Dasgupta P. An Inquiry into Well-Being and Destitution. Oxford: Clarendon Press, 1993.
93. Davey Smith G, Ebrahim S. Data dredging, bias, or confounding. BMJ 2002; 325: 1437-8.
94. Davey Smith G, Neaton JD, Wentworth D, et al. Mortality differences between black and white men in the usa: contribution of income and other risk factors among men screened for the mrfit. Lancet 1998; 351: 934-9.
95. Davidoff F. Evangelists and snails redux: the case of cholesterol screening. Ann Intern Med 1996; 124: 312-4.
96. DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications of insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-86.
97. De Laet CEDH, Van Hout BA, Burger H, et al. Hip fracture prediction in elderly men and women: validation in the Rotterdam Study. J Bone Miner Res 1998; 13: 1587-93.
98. De Smet PAGM. Herbal remedies. N Engl J Med 2002; 347: 2046-56.
99. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403.
100. Diez Roux AV, Merkin SS, Arnett D, et al. Neighborhood of residence and incidence of coronary heart disease. N Engl J Med 2001; 345: 99-106.
101. Djulbegovic B, Lacevic M, Cantor A, et al. The uncertainty principle and industry-sponsored research. Lancet 2000; 356: 635-8.
102. Drazen JM. Inappropriate advertising of dietary supplements. N Engl J Med 2003; 348: 777-8.
103. Drazen JM, Curfman GD. Financial associations of authors. N Engl J Med 2002; 346: 1901-2.
104. Druss BG, Marcus SC, Olfson M, et al. Trends in care by nonphysician clinicians in the United States. N Engl J Med 2003; 348: 130-7.
105. Eastham JA, Riedel E, Scardino PT, et al. Variation of serum prostatespecific-antigen levels. JAMA 2003; 289: 2695-700.
106. Edmond SL, Felson DT. Prevalence of back symptoms in elders. J Rheumatol 2000; 27: 220-5.
107. Edwards A, Unigwe S, Elwyn G, Hood K. Effects of communicating individual risks in screening programmes: Cochrane systematic review. BMJ 2003; 327: 703-9.
108. Elmore JG, Barton MB, Moceri VM, et al. Ten-year risk of false positive screening mammograms and clinical breast examinations. N Engl J Med 1998; 338: 1089-96.
109. Elmore JG, Wells C, Lee CH, et al. Variability in radiologists' interpretations of mammograms. N Engl J Med 1994; 331: 1493-9.
110. Engelhart MJ, Geerlings MI, Ruitenberg A, et al. Dietary intake of antioxidants and risk of Alzheimer disease. JAMA 2002; 287: 3223-9.
111. Ensrud KE, Duong T, Cauley JA, et al. Low fractional calcium absorption increases the risk for hip fracture in women with low calcium intake. Ann Intern Med 2000; 132: 345-53.
112. Erichsen JE. Railway and Other Injuries of the Nervous System. London: Walton and Maberly, 1866.
113. Ernst E. The risk-benefit profile of commonly used herbal therapies: ginkgo, St John's wort, ginseng, echinacea, saw palmetto, and kava. Ann Intern Med 2002; 136: 42-53.
114. Ernst E. Herbal medicines put into context. BMJ 2003; 327: 881-2.
115. Ettinger B, Black DM, Mitlak BH, et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene. JAMA 1999; 282: 637-45.
116. Fairfield KM, Fletcher RH. Vitamins for chronic disease prevention in adults. JAMA 2002; 287: 3116-26.
117. Farmer JA. Learning from the cerivastatin experience. Lancet 2001; 358: 1383-5.
118. Fawzi W, Stampfer MJ. A role for multivitamins in infection? Ann Intern Med 2003; 138: 430-1.
119. Felson DT, McAlindon TE. Glucosamine and chondroitin for osteoarthritis: to recommend or not to recommend? Arthritis Care Res 2000; 13: 179-82.
120. Ferrie JE, Shipley MJ, Marmot MG, Stansfeld SA, Davey Smith G. An uncertain future: the health effects of threats to employment security in white-collar men and women. Am J Public Health 1998; 88: 1030-6.
121. Feskanich D, Willett W, Colditz G. Walking and leisure-time activity and risk of hip fracture in postmenopausal women. JAMA 2002; 288: 2300-6.
122. Finkler K. Experiencing the New Genetics. Philadelphia: University of Pennsylvania Press, 2000.
123. Fischoff B, Wesseley S. Managing patients with inexplicable health problems. BMJ 2003; 326: 595-7.
124. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002; 347: 1233-41.
125. Fisher B, Jeong J-H, Anderson S, et al. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med 2002; 347: 567-75.
126. Fisher B, Redmond C, Fisher ER, et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 1985; 312: 674-81.
127. Fisher ES, Wennberg DE, Stukel TA, et al. The implications of regional variations in Medicare spending. Part 1: The content, quality, and accessibility of care. Ann Intern Med 2003; 138: 273-87.
128. Fisher ES, Wennberg DE, Stukel TA, et al. The implications of regional variations in Medicare spending. Part 2: Health outcomes and satisfaction with care. Ann Intern Med 2003; 138: 288-98.
129. Fitzpatrick R. Social status and mortality. Ann Intern Med 2001; 134: 1001-3.
130. Fletcher RH. Screening sigmoidoscopy-how often and how good? JAMA 2003; 290: 106-8.
131. Fletcher S, Colditz G. Failure of estrogen plus progestin therapy for prevention. JAMA 2002; 288: 366-8.
132. Fletcher S, Elmore JG. Mammographic screening for breast cancer. N Engl J Med 2003; 348: 1672-80.
133. Foley DJ, White LR. Dietary intake of antioxidants and risk of Alzheimer disease. JAMA 2002; 287: 3261-3.
134. Fonseca R, Hartmann LC, Petersen IV, et al. Ductal carcinoma in situ of the breast. Ann Intern Med 1997; 127: 1013-22.
135. Fontanarosa PB, Rennie D, DeAngelis CD. The need for regulation of dietary supplements-lessons from ephedra. JAMA 2003; 289: 1568-70.
136. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among us adults. JAMA 2002; 287: 356-9.
137. Forseth KØ, Husby G, Gran JT, Førre Ø. Prognostic factors for the development of fibromyalgia in women with self-reported musculoskeletal pain: a prospective study. J Rheumatol 1999; 26: 2458-67.
138. Foucault M. The Birth of the Clinic: An Archaeology of Medical Perception. Trans. A Sheridan. London: Tavistock, 1973.
139. Fransen M, McConnell S, Bell M. Therapeutic exercise for people with osteoarthritis of the hip or knee: a systematic review. J Rheumatol 2002; 29: 1737-45.
140. Frazier AL, Colditz GA, Fuchs CS, Kuntz KM. Cost-effectiveness of screening for colorectal cancer in the general population. JAMA 2000; 284: 1954-61.
141. Freemantle N, Calvert M, Woods J, Eastaugh J, Griffin C. Composite outcomes in randomized trials. JAMA 2003; 289: 2554-9.
142. Freidson E. Medical Work in America. New Haven: Yale University Press, 1989.
143. Friedman HS. Coronary bypass graft surgery: reexamining the assumptions. J Gen Intern Med 1990; 5: 80-3.
144. Furlan AD, Brosseau L, Imamura M, Irvin E. Massage for low-back pain: a systematic review within the framework of the Cochrane Collaboration Back Review Group. Spine 2002; 27: 1896-1910.
145. Gadamer H-G. The Enigma of Health: The Art of Healing in a Scientific Age. Trans. J Gaiger, N Walker. Stanford: Stanford University Press, 1996.
146. Gann PH, Morrow M. Combined hormone therapy and breast cancer. JAMA 2003; 290: 3304-6.
147. Garro LC. Chronic illness and the construction of narratives. In: Good M-J D, Brodwin PE, Good BJ, Kleinman A, eds. Pain as Human Experience. Berkeley: University of California Press, 1992: 100-37.
148. Gevitz N. Sectarian medicine. JAMA 1987; 257: 1636-40.
149. Gibson JNA, Grant IC, Waddell G. The Cochrane Review of surgery for lumbar disc prolapse and degenerative lumbar spondylosis. Spine 1999; 24: 1820-32.
150. Gillespie LD, Gillespie WJ, Cumming R, et al. Review: multiple risk factor modification reduces falls in elderly persons. In: The Cochrane Database of Systematic Reviews. The Cochrane Library. Oxford: Update Software; 1998, Issue 1.
151. Gøtzsche PC, Olsen O. Is screening for breast cancer with mammography justifiable? Lancet 2000; 355: 129-34.
152. Goldacre MJ, Roberts SE, Yeates D. Mortality after admission to hospital with fractured neck of femur: database study. BMJ 2002; 325: 868-9.
153. Goldberg RJ, Gore JM, Alpert JS, Dalen JE. Recent changes in attack and survival rates of acute myocardial infarction (1975-1981). JAMA 1986; 255: 2774-9.
154. Gomez-Marin O, Folsom AR, Kottke TE, et al. Improvement in the long-term survival among patients hospitalized with acute myocardial infarction, 1970-1980. N Engl J Med 1987; 21: 1354-9.
155. Goodman SN. The mammography dilemma: a crisis for evidence-based medicine? Ann Intern Med 2002; 137: 363-5.
156. Graat JM, Schouten EG, Kok FJ. Effect of daily vitamin E and multivitamin-mineral supplementation on acute respiratory tract infections in elderly persons. JAMA 2002; 288: 715-21.
157. Greenhalgh S. Under the Medical Gaze: Facts and Fictions of Chronic Pain. Berkeley: University of California Press, 2001.
158. Greenspan SL, Emkey RD, Bone HG, et al. Significant differential effects of alendronate, estrogen, or combination therapy on the rate of bone loss after discontinuation of treatment of postmenopausal osteoporosis. Ann Intern Med 2002; 137: 875-83.
159. Greenspan SL, Myers ER, Maitland LA, et al. Fall severity and bone mineral density as risk factors for hip fracture in ambulatory elderly. JAMA 1994; 271: 128-33.
160. Gregg EW, Cauley JA, Stone K, et al. Relationship of changes in physical acitivity and mortality among older women. JAMA 2003; 289: 2379-86.
161. Gregg EW, Gerzoff RB, Thompson TJ, Williamson DF. Intentional weight loss and death in overweight and obese us adults 35 years of age and older. Ann Intern Med 2003; 138: 383-9.
162. Grodstein F, Clarkson TB, Manson JE. Understanding the divergent data on postmenopausal hormone therapy. N Engl J Med 2003; 348: 645-50.
163. Guastello SJ, Johnson EA, Rieke ML. Nonlinear dynamics of motivational flow. Nonlinear Dynamics, Psychology, and Life Sciences 1999; 3: 259-73.
164. Gureje O, von Korff M, Simon GE, Gater R. Persistent pain and wellbeing: a World Health Organization study in primary care. JAMA 1998; 280: 147-51.
165. Gurwitz JH, Field TS, Harrold LR, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 2003; 289: 1107-16.
166. Hacohen M. Karl Popper: The Formative Years 1902-1945. Cambridge: Cambridge University Press, 2000.
167. Hacking I. The Social Construction of What? Cambridge: Harvard University Press, 2000.
168. Hadler NM. There's the forest: the object lesson of nsaid gastropathy. J Rheumatol 1990; 17: 280-2.
169. Hadler NM. Knee pain is the malady-not osteoarthritis. Ann Intern Med 1992; 116: 598-9.
170. Hadler NM. The injured worker and the internist. Ann Intern Med 1994; 120: 163-4.
171. Hadler NM. If you have to prove you are ill, you can't get well: the object lesson of fibromyalgia. Spine 1996; 21: 2397-400.
172. Hadler NM. Workers' compensation and chronic regional musculoskeletal pain. Brit J Rheumatol 1998; 37: 815-8.
173. Hadler NM. Laboring for longevity. J Occup Environ Med 1999; 41: 617-21.
174. Hadler NM. Back pain. Chapter 13.2. In: Evans JG, Williams TF, Beattie BL, Michel J-P, Wilcock GK, eds. Oxford Textbook of Geriatric Medicine. 2nd ed. Oxford: Oxford University Press, 2000: 559-65.
175. Hadler NM. Chiropractic. Rheum Dis Clin of North Am 2000; 26: 97-102.
176. Hadler NM. The "ergonomics injury" as a social construction. Workers' Compensation Policy Review 2001; 1: 20-5.
177. Hadler NM. Rheumatology and the health of the workforce. Arthritis Rheum 2001; 44: 1971-4.
178. Hadler NM. Options in disability determination: lessons that pertain to the regional musculoskeletal disorders. J Rheumatol 2002; 29: 407-10.
179. Hadler NM. Point of view on the paper by Coulter et al. Spine 2002; 27: 297-8.
180. Hadler NM. A ripe old age. Arch Intern Med 2003; 163: 1261-2.
181. Hadler NM. "Fibromyalgia" and the medicalization of misery. J Rheumatol 2003; 30: 1668-70.
182. Hadler NM. MRI for regional back pain: need for less imaging, better understanding. JAMA 2003; 289: 2863-5.
183. Hadler NM. The semiotics of "upper limb musculoskeletal disorders in workers." J Clin Epidemiol 2003; 56: 937-9.
184. Hadler NM. Occupational Musculoskeletal Disorders. 3rd ed. Philadelphia: Lippincott Williams & Wilkins, 2004.
185. Hadler NM, Curtis P, Gillings DB, Stinnett S. A benefit of spinal manipulation as adjunctive therapy for acute low back pain: a stratified controlled trial. Spine 1987; 12: 703-6.
186. Hadler NM, Evans JP. Commentary on "The Kin in the Gene." Current Anthropology 2001; 42: 252-3.
187. Hadler NM, Gillings DB. On the design of the phase III drug trial. Arthritis Rheum 1983; 26: 1354-61.
188. Hagen KB, Hilde G, Jamtvedt G, Winnem MF. The Cochrane Review of advice to stay active as a single treatment for low back pain and sciatica. Spine 2002: 27: 1736-41.
189. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment and control of hypertension in the United States, 1988-2000. JAMA 2003; 290: 199-206.
190. Haller CA, Benowitz NL. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Engl J Med 2000; 343: 1833-8.
191. Hanger HC, Smart EJ, Marrilees MJ, Frampton CM. The prevalence of malnutrition in elderly hip fracture patients. NZ Med J 1999; 112: 88-90.
192. Hannan EL, Magaziner J, Wang JJ, et al. Mortality and locomotion 6 months after hospitalization for hip fracture. JAMA 2001; 285: 2736-42.
193. Hannan EL, Racz MJ, Walford G, et al. Predictors of readmission for complications of coronary artery bypass graft surgery. JAMA 2003; 290: 773-80.
194. Harris R, Lohr KN. Screening for prostate cancer: an update of the evidence for the us Preventive Services Task Force. Ann Intern Med 2002; 137: 917-29.
195. Harris ST, Watts NB, Genant HK, et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis. JAMA 1999; 282: 1344-52.
196. Hassett AL, Cone JD, Patella SJ, Sigal LH. The role of catastrophizing in the pain and depression of women with fibromyalgia syndrome. Arthritis Rheum 2000; 43: 2493-500.
197. Hays J, Ockene JK, Brunner RL, et al. Effects of estrogen plus progestin on health-related quality of life. N Engl J Med 2003; 348: 1839-54.
198. He K, Merchant A, Rimm EB, et al. Dietary fat intake and risk of stroke in male us healthcare professionals: 14 year prospective cohort study. BMJ 2003; 327: 777-81.
199. Heart Outcomes Prevention Evaluation Study Investigators. Vitamin E supplementation and cardiovascular events in high-risk patients. N Engl J Med 2000; 342: 154-60.
200. Hemingway H, Crook AM, Feder G, et al. Underuse of coronary revascularization procedures in patients considered appropriate candidates for revascularization. N Engl J Med 2001; 344: 645-54.
201. Hemingway H, Shipley M, Britton A, Page M, Macfarlane P, Marmot M. Prognosis of angina with and without a diagnosis: 11 year follow up in the Whitehall II prospective cohort study. BMJ 2003; 327: 895-99.
202. Hemingway H, Shipley MJ, Stansfeld S, Marmot M. Sickness absence from back pain, psychosocial work characteristics and employment grade among office workers. Scand J Work Environ Health 1997; 23: 121-9.
203. Herman J. Reflections on playing God engendered by a chat with L. Perspectives Biol Med 1993; 36: 592-5.
204. Hertzman C. Health and human society. American Scientist 2001; 89: 538-45.
205. Hertzman-Miller RR, Morgenstern H, Hurwitz EL, et al. Comparing the satisfaction of low back pain patients randomized to receive medical or chiropractic care: results from the ucla low-back pain study. Am J Public Health 2002; 92: 1628-33.
206. Hlatky M. Patient preferences and clinical guidelines. JAMA 1995; 273: 1219-20.
207. Hlatky MA, Boothroyd D, Vittinghoff E, et al. Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy. JAMA 2002; 287: 591-7.
208. Hoes AW, Grobbee DE, Lubsen J, et al. Diuretics, ß-blockers, and the risk for sudden cardiac death in hypertensive patients. Ann Intern Med 1995; 123: 481-7.
209. Holmberg L, Bill-Axelson A, Helgesen F, et al. A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med 2002; 347: 781-9.
210. Holmes OW. Medical Essays: 1842-1882. Boston: Houghton Mifflin, 1899.
211. Hoogendoorn WE, van Poppel MNM, Bongers PM, et al. Systematic review of psychosocial factors at work and private life as risk factors for back pain. Spine 2000; 25: 2114-25.
212. Hoving JL, Gross AR, Gasner D, et al. A critical appraisal of review articles on the effectiveness of conservative treatment for neck pain. Spine 2001; 26: 196-205.
213. Hu FB, Bronner L, Willett WC, et al. Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. JAMA 2002; 287: 1815-21.
214. Hu FB, Stampfer MJ, Rimm EB, et al. A prospective study of egg consumption and risk of cardiovascular disease in men and women. JAMA 1999; 281: 1387-94.
215. Humphrey LL, Chan GKS, Sox HC. Postmenopausal hormone replacement therapy and the primary prevention of cardiovascular disease. Ann Intern Med 2002; 137: 273-84.
216. Humphrey LL, Helfand M, Chan BKS, Woolf SH. Breast cancer screening: a summary of the evidence for the us Preventive Services Task Force. Ann Intern Med 2002; 137: 347-60.
217. Hunt, IM, Silman, AJ, Benjamin, S, et al. The prevalence and associated features of chronic widespread pain in the community using the "Manchester" definition of chronic widespread pain. Rheumatology 1999; 38: 275-9.
218. Imperiale TF. Aspirin and the prevention of colorectal cancer. N Engl J Med 2003; 348: 879-80.
219. Imperiale TF, Wagner DR, Lin CY, et al. Results of screening colonoscopy among persons 40 to 49 years of age. N Engl J Med 2002; 346: 1781-5.
220. Irnich D, Beharens N, Molzen H, et al. Randomised trial of acupuncture compared with conventional massage and "sham" laser acupuncture for treatment of chronic neck pain. BMJ 2001; 322: 1574-8.
221. Jackson SA, Tenenhouse A, Robertson L, et al. Vertebral fracture definition from population-based data: preliminary results from the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int 2000; 11: 680-7.
222. Jacobs AK. Primary angioplasty for acute myocardial infarction-is it worth the wait? N Engl J Med 2003; 349: 798-800.
223. Jha P, Flather M, Lonn E, et al. The antioxidant vitamins and cardiovascular disease: a critical review of epidemiologic and clinical trial data. Ann Intern Med 1995; 123: 860-72.
224. Johnston JM, Landsittel DP, Nelson NA, et al. Stressful psychosocial work environment increases risk for back pain among retail material handlers. Am J Ind Med 2003; 43: 179-87.
225. Johnstone RT. Occupational Diseases: Diagnosis, Medicolegal Aspects and Treatment. Philadelphia: Saunders, 1941.
226. Joines JD, Hadler NM. Back pain. Chapter 100. In: Wachter RM, Goldman L, Hollander H, eds. Hospital Medicine. Philadelphia: Lippincott Williams & Wilkins, 2000: 961-8.
227. Jonas WB, Kaptchuk TJ, Linde K. A critical overview of homeopathy. Ann Intern Med 2003; 138: 393-9.
228. Jüni P, Rutjes AWS, Dieppe PA. Are selective cox 2 inhibitors superior to traditional non-steroidal anti-inflammatory durgs? BMJ 2002; 324: 1287-8.
229. Kalb PE, Koehler KG. Legal issues in scientific research. JAMA 2002; 287: 85-91.
230. Kannus P, Parkkari J, Koskinen S, et al. Fall-induced injuries and deaths among older adults. JAMA 1999; 281: 1895-9.
231. Kannus P, Parkkari J, Niemi S, et al. Prevention of hip fracture in elderly people with use of a hip protector. N Engl J Med 2000; 343: 1506-13.
232. Kaplan JB, Bennett T. Use of race and ethnicity in biomedical publication. JAMA 2003; 289: 2709-16.
233. Kaptchuk TJ. The placebo effect in alternative medicine: can the performance of a healing ritual have clinical significance? Ann Intern Med 2002; 136: 817-25.
234. Kaptchuk TJ. Effect of interpretive bias on research evidence. BMJ 2003; 326: 1453-5.
235. Kaptchuk TJ, Eisenberg DM. The persuasive appeal of alternative medicine. Ann Intern Med 1998; 129: 1061-5.
236. Karasek RA, Theorell T. Healthy Work. New York: Basic Books, 1990.
237. Katz JN. Patient preferences and health disparities. JAMA 2001; 286: 1506-8.
238. Kaufman M. Homeopathy in America: the rise and fall and persistence of a medical heresy. In: Gevitz N, ed. Other Healers: Unorthodox Medicine in America. Baltimore: Johns Hopkins University Press, 1988: 99-123.
239. Kawachi I, Berkman LF, eds. Neighborhoods and Health. New York: Oxford University Press, 2003.
240. Kawachi I, Kennedy BP, Wilkinson RG, eds. The Society and Population Health Reader. Vol. 1: Income Inequality and Health. New York: The New Press, 1999.
241. Kelch RP. Maintaining the public trust in clinical research. N Engl J Med 2002; 346: 285-7.
242. Keller T, Chappell T. The rise and fall of Erichsen's disease (railway spine). Spine 1996; 21: 1597-601.
243. Kersh BC, Bradley LA, Alarcón GS, et al. Psychosocial and health status variables independently predict health care seeking in fibromyalgia. Arthritis Care Res 2001; 45: 362-71.
244. King SB. Why have stents replaced balloons? underwhelming evidence. Ann Intern Med 2003; 138: 842-3.
245. Kjaergard LL, Als-Nielsen B. Associations between competing interests and authors' conclusions: epidemiological study of randomized clinical trials published in the BMJ. BMJ 2002; 325: 249-52.
246. Klauokalani D, Sherman KJ, Cherkin DC. Acupuncture for chronic low back pain: diagnosis and treatment patterns among acupuncturists evaluating the same patient. South Med J 2001; 94: 486-92.
247. Koes BW, Assendelft WJ, van der Heijden GJ, Bouter LM. Spinal manipulation for low back pain: an updated systematic review of randomized clinical trials. Spine 1996; 21: 2860-71.
248. Korn D. Conflicts of interest in biomedical research. JAMA 2000; 284: 2234-7.
249. Krzyzanowska MK, Pintilie M, Tannock IF. Factors associated with failure to publish large randomized trials presented at an oncology meeting. JAMA 2003; 290: 495-501.
250. Kubzansky LD, Kawachi I, Sparrow D. Socioeconomic status, hostility, and risk factor clustering in the normative aging study: any help from the concept of allostatic load? Ann Behav Med 1999; 21: 330-8.
251. Kuhn T. The Structure of Scientific Revolutions. 2nd ed. Chicago: University of Chicago Press, 1970.
252. Kumana CR, Cheung BMY, Lauder IJ. Gauging the impact of statins using number needed to treat. JAMA 1999; 282: 1899-901.
253. Laine L, Wogen J, Yu H. Gastrointestinal health care resource utilization with chronic use of cox-2-specific inhibitors versus traditional nsaids. Gastroenterology 2003; 125: 389-95.
254. Lakka H-M, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709-16.
255. Lakka TA, Venäläinen JM, Rauramaa R, et al. Relation of leisure-time physical activity and cardiorespiratory fitness to the risk of acute myocardial infarction in men. N Engl J Med 1994; 330: 1549-54.
256. Lantz PM, House JS, Lepkowski JM, et al. Socioeconomic factors, health behaviors, and mortality. JAMA 1998; 279: 1703-8.
257. Lasser KE, Allen PD, Woolhandler SJ, et al. Timing of new black box warnings and withdrawals for prescription medications. JAMA 2002; 287: 2215-20.
258. Lauer MS, Topol EJ. Clinical trials-multiple treatments, multiple end points, and multiple lessons. JAMA 2003; 289: 2575-7.
259. Lavizzo-Mourey R, Knickman JR. Racial disparities-the need for research and action. N Engl J Med 2003; 349: 1379-80.
260. Law MR, Wald NJ, Morris JK, Jordan RE. Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. BMJ 2003; 326: 1427-35.
261. LeBoff MS, Kohlmeier L, Hurwitz S, Franklin J, Wright J, Glowacki J. Occult vitamin D deficiency in postmenopausal women with acute hip fracture. JAMA 1999; 281: 1505-11.
262. Leeb BF, Schweitzer H, Montag K, Smolen JS. A meta-analysis of chondroitin sulfate in the treatment of osteoarthritis. J Rheumatol 2000; 27: 205-11.
263. Leipzig RM, Cumming RG, Tinetti ME. Drugs and falls in older people: a systematic review and meta-analysis: II. Cardiac and analgesic drugs. J Am Geriatr Soc 1999; 47: 40-50.
264. Lerman C, Trock B, Rimer BK, et al. Psychological and behavioral implications of abnormal mammograms. Ann Intern Med 1991; 114: 657-61.
265. Lerner BH. Fighting the war on breast cancer: debates over early detection, 1945 to the present. Ann Intern Med 1998; 129: 74-8.
266. Levy D, Thom TJ. Death rates from coronary disease-progress and a puzzling paradox. N Engl J Med 1998; 339: 915-7.
267. Lexchin J, Bero LA, Djulbegovic B, Clark O. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ 2003; 326: 1167-77.
268. Lieberman DA, Weiss DG, for the Veterans Affairs Cooperative Study Group. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N Engl J Med 2001; 345: 555-60.
269. Lieberman DA, Weiss DG, Bond JH, et al. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. N Engl J Med 2000; 343: 162-8.
270. Linde K, Mulrow CD. St. John's wort for depression. Cochrane Review, Cochrane Library, Oxford: Update Software, 1998.
271. Lindsay R, Silverman SL, Cooper C, et al. Risk of new vertebral fracture in the year following a fracture. JAMA 2001; 285: 320-3.
272. Linton SJ. A review of psychological risk factors in back and neck pain. Spine 2000; 25: 1148-56.
273. Linton SJ, Van Tulder MW. Preventive interventions for back and neck pain problems: what is the evidence? Spine 2001; 26: 778-87.
274. Lips P. Hypervitaminosis A and fractures. N Engl J Med 2003; 348: 347-9.
275. Lipsky PE, Abramson SB, Breedveld FC, et al. Analysis of the effect of cox-2 specific inhibitors and recommendations for their use in clinical practice. J Rheumatol 2000; 27: 1338-40.
276. Lucire Y. Constructing RSI: Belief and Desire. Sydney: University of New South Wales Press, 2003.
277. Lu-Yao G, Albertsen PC, Stanford JL, et al. Natural experiment examining impact of aggressive screening and treatment on prostate cancer mortality in two fixed cohorts from Seattle area and Connecticut. BMJ 2002; 325: 740-3.
278. Lynch HT, de la Chapelle A. Hereditary colorectal cancer. N Engl J Med 2003; 348: 919-32.
279. Macfarlane GJ, Morris S, Hunt IM, et al. Chronic widespread pain in the community: the influence of psychological symptoms and mental disorder on healthcare seeking behavior. J Rheumatol 1999; 26: 413-9.
280. Macfarlane GJ, Thomas E, Papageorgiou AC, et al. The natural history of chronic pain in the community: a better prognosis than in the clinic? J Rheumatol 1996; 23: 1617-20.
281. Mahoney EM, Jurkovitz CT, Chu H, et al. Cost and cost-effectiveness of an early invasive vs conservative strategy for the treatment of unstable angina and non-st-segment elevation myocardial infarction. JAMA 2002; 288: 1851-8.
282. Main CJ, Williams AC. Musculoskeletal pain. BMJ 2002; 325: 534-7.
283. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993; 328: 1365-71.
284. Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000; 343: 1603-7.
285. Mann CC, Plummer ML. The Aspirin Wars. New York: Knopf, 1991.
286. Manson JE, Hsia J, Johnson KC, et al. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 2003; 349: 523-34.
287. March LM, Cameron ID, Cumming RG, et al. Mortality and morbidity after hip fracture: can evidence based clinical pathways make a difference? J Rheumatol 2000; 27: 2227-31.
288. Marcus AJ, Broekman MJ, Pinsky DJ. COX inhibitors and thrombophilia. N Engl J Med 2002; 347: 1025-6.
289. Marcus DM, Grollman AP. Botanical medicines-the need for new regulations. N Engl J Med 2002; 347: 2073-6.
290. Mark DB, Newman MF. Protecting the brain in coronary artery bypass graft surgery. JAMA 2002; 287: 1448-50.
291. Marmot M, Wilkinson RH, eds. Social Determinants of Health. Oxford: Oxford University Press, 1999.
292. Marra CA, Esdaile JM, Sun H, Anis AH. The cost of cox inhibitors: how selective should we be? J Rheumatol 2000; 27: 2731-3.
293. Masud T, Francis RM. The increasing use of peripheral bone densitometry. BMJ 2000; 321: 306-8.
294. McAlindon TE, LaValley MP, Gulin JP, Felson DT. Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis. JAMA 2000; 283: 1469-75.
295. McCally M, Haines A, Fein O, et al. Poverty and ill health: physicians can, and should, make a difference. Ann Intern Med 1998; 129: 726-33.
296. McClung MR, Geusens P, Miller PD, et al. Effect of risedronate on the risk of hip fracture in elderly women. N Engl J Med 2001; 344: 333-40.
297. McDonald CJ. Medical heuristics: the silent adjudicators of clinical practice. Ann Intern Med 1996; 124: 56-62.
298. McGovern PG, Pankow JS, Shahar E, et al. Recent trends in acute coronary heart disease. N Engl J Med 1996; 334: 884-90.
299. McLeod RS and members of the Canadian Task Force on Preventive Health Care. Screening strategies for colorectal cancer: a systematic review of the evidence. Can J Gastroenterol 2001; 15:647-60.
300. McTigue KM, Garrett JM, Popkin BM. The natural history of the development of diabetes in a cohort of young us adults between 1981 and 1998. Ann Intern Med 2002; 136: 857-64.
301. McWhinney IR, Epstein RM, Freeman TR. Rethinking somatization. Ann Intern Med 1997; 126: 747-50.
302. Meeker WC, Haldeman S. Chiropractic: a profession at the crossroads of mainstream and alternative medicine. Ann Intern Med 2002; 136: 216-27.
303. Meigs JB. The metabolic syndrome. BMJ 2003; 327: 61-2.
304. Melander H, Ahlqvist-Rastad J, Meijer G, Beermann B. Evidence b(i)ased medicine-selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications. BMJ 2003; 326: 1171-6.
305. Michaëlsson K, Lithell H, Vessby B, Melhus H. Serum retinol levels and the risk of fracture. N Engl J Med 2003; 348: 287-94.
306. Miettinen OS, Henschke CI, Pasmantier MW, et al. Does mammography save lives? Can Med Assoc J 2002; 166: 1187-8.
307. Miettinen OS, Henschke CI, Pasmantier MW, et al. Mammographic screening: no reliable supporting evidence? Lancet 2002; 359: 404-6; http://image.theLancet.com/extras/1093web.pdf.
308. Mikkelsson, M, Kaprio, J, Salminen, JJ, et al. Widespread pain among 11-year-old Finnish twin pairs. Arthritis Rheum 2001; 44: 481-5.
309. Miller AB, Baines CJ, To T, Wall C. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years. Can Med Assoc J 1992; 147: 1459-76.
310. Miller AB, Baines CJ, To T, Wall C. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years. Can Med Assoc J 1992; 147: 1477-88.
311. Miller AB, To T, Baines CJ, Wall C. Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50-59 years. J Natl Cancer Inst 2000; 92: 1490-9.
312. Miller AB, To T, Baines CJ, Wall C. The Canadian National Breast Screening Study-1: Breast cancer mortality after 11 to 16 years of follow-up. Ann Intern Med 2002; 137: 305-12.
313. Miller D. Popper Selections. Princeton: Princeton University Press, 1985.
314. Miller FG, Rosenstein DL, DeRenzo EG. Professional integrity in clinical research. JAMA 1998; 280: 1449-54.
315. Mills JL. Data torturing. N Engl J Med 1993; 329: 1196-9.
316. Mixter WJ, Barr JS. Rupture of the intervertebral disc with involvement of the spinal canal. N Engl J Med 1934; 211: 210-5.
317. Mohren DCL, Swaen GMH, van Amelsvoort LGPM, et al. Job insecurity as a risk factor for common infections and health complaints. J Occup Environ Med 2003; 45: 123-9.
318. Morin K, Rakatansky H, Riddick FA, et al. Managing conflicts of interest in the conduct of clinical trials. JAMA 2002; 287: 78-84.
319. Morris CD, Carson S. Routine vitamin supplementation to prevent cardiovascular disease: a summary of the evidence for the us Preventive Services Task Force. Ann Intern Med 2003; 139: 56-70.
320. Morris MC, Evans DA, Bienias JL, et al. Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study. JAMA 2002; 287: 3230-7.
321. Morrow M, Schnitt SJ. Treatment selection in ductal carcinoma in situ. JAMA 2000; 283: 453-5.
322. Mortality Morbidity Weekly Report (CDC) 1994; 43: 586.
323. Moseley JB, O'Malley K, Petersen NJ, et al. A controlled trial of arthroscopic surgery for osteoarthritis of the knee. N Engl J Med 2002; 347: 81-8.
324. Moses H, Braunwald E, Martin JB, Their SO. Collaborating with industry-choices for the academic medical center. N Engl J Med 2002; 347: 1371-5.
325. Mukherjee D, Nissen SE, Topol EJ. Risk of cardiovascular events associated with selective cox-2 inhibitors. JAMA 2001; 286: 954-9.
326. Multiple Risk Factor Intervention Trial Research Group. Multiple Risk Factor Intervention Trial: risk factor changes and mortality. JAMA 1982; 248: 182-7.
327. Musgrave DS, Vogt MT, Nevitt MC, Cauley JA. Back problems among postmenopausal women taking estrogen replacement therapy. Spine 2001; 26: 1606-12.
328. Narayan KMV, Boyle JP, Thompson TJ, Sorensen SW, Williamson DF. Lifetime risk for diabetes mellitus in the United States. JAMA 2003; 290: 1884-90.
329. National Cholesterol Education Program (NCEP). Executive summary of the third report on detection, evaluation and treatment of high blood cholesterol in adults. JAMA 2001; 285: 2486-97.
330. National Institutes of Health. Osteoporosis prevention, diagnosis and therapy. NIH Consensus Statement 2000; 17: 1-45.
331. National Institutes of Health. Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Bethesda, md: National Institutes of Health, 2001. NIH Publication 01-3670.
332. National Institutes of Health Consensus Development Panel on Osteoporosis Prevention, Diagnosis and Therapy. Osteoporosis prevention, diagnosis and therapy. JAMA 2001; 285: 785-95.
333. National Task Force on the Prevention and Treatment of Obesity. Weight cycling. JAMA 1994; 272: 1196-202.
334. Natvig B, Bruusgaard D, Eriksen W. Localized low back pain and low back pain as part of widespread musculoskeletal pain: two different disorders? a cross-sectional population study. J Rehabil Med 2001; 33: 21-5.
335. Neer RM, Arnaud CD, Zanchetta JR, et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 2001; 344: 1434-41.
336. Neerinckx J, van Houdenhove B, Lysens R, et al. Attributions in chronic fatigue syndrome and fibromyalgia syndrome in tertiary care. J Rheumatol 2000; 27: 1051-5.
337. Nelemans PJ, deBie RA, deVet HCW, Sturmans F. Injection therapy for subacute and chronic benign low back pain. Spine 2001; 26: 501-15.
338. Nelson HD, Helfand M, Woolf SH, Allan JD. Screening for postmenopausal osteoporosis: a review of the evidence for the us Preventive Services Task Force. Ann Intern Med 2002; 137: 529-41.
339. Nelson HD, Humphrey LL, Nygren P, et al. Postmenopausal hormone replacement therapy. JAMA 2002; 288: 872-81.
340. Nelson SP, Bärenholdt O, Diessel E, Armbrust S, Felsenberg D. Linearity and accuracy errors in bone densitometry. Brit J Radiology 1998; 71: 1062-8.
341. Nevitt MC, Ettinger B, Black DM, et al. The association of radiographically detected vertebral fractures with back pain and function: a prospective study. Ann Intern Med 1998; 128: 793-800.
342. Newman KS. No Shame in My Game: The Working Poor in the Inner City. New York: AA Knopf and The Russell Sage Foundation, 1999.
343. Newman MF, Kirchner JL, Phillips-Bute B, et al. Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. N Engl J Med 2001; 344: 395-402.
344. Nicassio PM, Weisman MH, Schuman C, Young CW. The role of generalized pain and pain behavior in tender point scores in fibromyalgia. J Rheumatol 2000; 27: 1056-62.
345. Nolan CM. Credibility, cookbook medicine, and common sense: guidelines and the College. Ann Intern Med 1994; 120: 966-7.
346. Nuovo J. Reporting number needed to treat and absolute risk reduction in randomized controlled trials. JAMA 2002; 287: 2813-4.
347. Olsen O, Gøtzsche PC. Cochrane review on screening for breast cancer with mammography. Lancet 2001; 358: 1340-2.
348. Orwoll E, Ettinger M, Weiss S, et al. Alendronate for the treatment of osteoporosis in men. N Engl J Med 2000; 343: 604-10.
349. Page DL, Jensen RA. Ductal carcinoma in situ of the breast. JAMA 1996; 275: 948-9.
350. Page DL, Simpson JF. Ductal carcinoma in situ-the focus for prevention, screening and breast conservation in breast cancer. N Engl J Med 1999; 340: 1499-500.
351. Pamuk E, Makuc D, Heck K, et al. Socioeconomic Status and Health Chartbook: Health, United States, 1998. Hyattsville, md: National Center for Health Statistics, 1998.
352. Parker MJ, Gillespie LD, Gillespie WJ. Hip protectors for preventing hip fractures in the elderly. Cochrane Review, 1 May 1999. In: The Cochrane Library. Oxford: Update Software.
353. Passamani E, Davis KB, Gillespie MJ, Killip T, and the cass Principal Investigators and Their Associates. A randomized trial of coronary artery bypass surgery: survival of patients with a low ejection fraction. N Engl J Med 1985; 312: 1665-71.
354. Pasternak RC. The allhat lipid lowering trial-less is less. JAMA 2002; 288: 3042-4.
355. Payer L. Medicine and Culture. New York: Holt, 1988: 139-43.
356. Pell S, Fayerweather WE. Trends in the incidence of myocardial infarction and in associated mortality and morbidity in a large employed population 1957-1983. N Engl J Med 1985; 16: 1005-11.
357. Pendleton A, Arden N, Dougados M, et al. EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (escisit). Ann Rheum Dis 2000; 59: 936-44.
358. Perry HM, Davis BR, Price TR, et al. Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke. JAMA 2000; 284: 465-71.
359. Pfisterer M, Buser P, Osswald S, et al. Outcome of elderly patients with chronic symptomatic coronary artery disease with an invasive vs optimized medical treatment strategy. JAMA 2003; 289: 1117-23.
360. Phillips K-A, Glendon G, Knight JA. Putting the risk of breast cancer in perspective. N Engl J Med 1999; 340: 141-4.
361. Phillips PS, Haas RH, Bannykh S, et al. Statin-associated myopathy with normal creatine kinase levels. Ann Intern Med 2002; 137: 581-5.
362. Pignone M, Phillips C, Mulrow C. Use of lipid lowering drugs for primary prevention of coronary heart disease: meta-analysis of randomized trials. BMJ 2000; 321: 983-6.
363. Pignone M, Saha S, Heorger T, Mandelblatt J. Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the us Preventive Services Task Force. Ann Intern Med 2002; 137: 96-104.
364. Pincus T, Burton AK, Vogel S, Field AP. A systematic review of psychological factors as predictors of chronicity/disability in prospective cohorts of low back pain. Spine 2002; 27: E109-E120.
365. Podolsky DK. Going the distance-the case for true colorectal-cancer screening. N Engl J Med 2000; 343: 207-8.
366. Popper K. Conjectures and Refutations. London: Routledge, 2000.
367. Premier Collaborative Research Group. Effects of comprehensive lifestyle modification on blood pressure control. JAMA 2003; 289: 2083-93.
368. Price JR, Couper J. Cognitive behaviour therapy for adults with chronic fatigue syndrome. Cohcrane Review, 24 August 1998. In: The Cochrane Library. Oxford: Update software.
369. Psaty BM, Lumley T, Furberg CD, et al. Health outcomes associated with various antihypertensive therapies used as first-line agents. JAMA 2003; 289: 2534-44.
370. Psaty BM, Weiss NS, Furberg CD, et al. Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular disease. JAMA 1999; 282: 786-90.
371. Ransohoff DF, Collins MM, Fowler FJ. Why is prostate cancer screening so common when the evidence is so uncertain? a system without negative feedback. Am J Med 2002; 113: 663-7.
372. Ransohoff DF, Sandler RS. Screening for colorectal cancer. N Engl J Med 2002; 346: 40-4.
373. Rapp SR, Espeland MA, Shumaker SA, et al. Effect of estrogen plus progestin on global cognitive function in postmenopausal women. JAMA 2003; 289: 2663-72.
374. Ray WA, Stein CM, Daugherty JR, et al. COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease. Lancet 2002; 360: 1071-3.
375. Reaven GM. Importance of identifying the overweight patient who will benefit the most by losing weight. Ann Intern Med 2003; 138: 420-3.
376. Reid IR, Brown JP, Burckhardt P, et al. Intravenous zoledronic acid in postmenopausal women with low bone mineral density. N Engl J Med 2002: 346: 653-61.
377. Reissman DB, Orris P, Lacey R, Hartman DE. Downsizing, role demands, and job stress. J Occup Environ Med 1999; 41: 289-93.
378. Rekola KE, Levoska S, Takala J, Keinänen-Kiukaanniemi S. Patients with neck and shoulder complaints and multisite musculoskeletal symptoms-a prospective study. J Rheumatol 1997; 24: 2424-8.
379. Relman AS. Dealing with conflicts of interest. N Engl J Med 1984; 310: 1182-3.
380. Relman AS. New "information for authors"-and readers. N Engl J Med 1990; 323: 56.
381. Relman AS. Separating continuing medical education from pharmaceutical marketing. JAMA 2001; 285: 2009-12.
382. Relman AS. Financial associations of authors. N Engl J Med 2002; 347: 1043.
383. Relman AS. Defending professional independence. JAMA 2003; 289: 2418-20.
384. Rennie D, Luft HS. Pharmacoeconomic analyses. Making them transparent, making them credible. JAMA 2000; 283: 2158-60.
385. Rex DK, Cutler CS, Lemmel GT, et al. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology 1997: 112: 24-8.
386. Rey R. The History of Pain. Cambridge, ma: Harvard University Press, 1995.
387. Riggs BL, Hartmann LC. Selective estrogen-receptor modulators-mechanisms of action and application to clinical practice. N Engl J Med 2003; 348: 618-29.
388. Rimm EB, Ascherio A, Giovannucci E, et al. Vegetable, fruit and cereal fiber intake and risk of coronary heart disease among men. JAMA 1996; 275: 447-51.
389. RITA-2 trial participants. Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (rita-2). Lancet 1997; 350: 461-8.
390. Roberts SE, Goldacre MJ. Time trends and demography of mortality after fractured neck of femur in an English population, 1968-98 database study. BMJ 2003; 327: 771-5.
391. Roos H, Laurén M, Adalberth T, et al. Knee osteoarthritis after meniscectomy. Arthritis Rheum 1998; 41: 687-93.
392. Rosa L, Rosa E, Sarner L, Barrett S. A close look at therapeutic touch. JAMA 1998; 279: 1005-10.
393. Rosamond WD, Chambless LE, Folsom AR, et al. Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987-1994. N Engl J Med 1998; 339: 861-7.
394. Rosenthal MB, Berndt ER, Donohue JM, et al. Promotion of prescription drugs to consumers. N Engl J Med 2002; 346: 498-505.
395. Rothman K. Causal Inference. Cambridge: Epidemiology Resources, 1988.
396. Rubenstein LZ. Hip protectors-a breakthrough in fracture prevention. N Engl J Med 2000; 343: 1562-3.
397. Rubenstein LZ, Josephson KR, Trueblood PR, et al. Effects of a group exercise program on strength mobility and falls among fall-prone elderly men. J Gerontol 2000; 55A: M317-21.
398. Salkeld G, Cameron ID, Cumming RG, et al. Quality of life related to fear of falling and hip fracture in older women: a time trade off study. BMJ 2000; 320: 241-6.
399. Sandler RS, Halabi S, Baron JA, et al. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med 2003; 348: 883-90.
400. Satariano WA, Ragland DR. The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann Intern Med 1994; 120: 104-10.
401. Scardino PT. The prevention of prostate cancer-the dilemma continues. N Engl J Med 2003; 349: 297-300.
402. Scarry E. The Body in Pain. New York: Oxford University Press, 1985.
403. Schnyder G, Roffi M, Flammer Y, Pin R, Hess OM. Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention. JAMA 2002; 288: 973-9.
404. Schoen RE, Pinsky PF, Weissfeld JL, et al. Results of repeat sigmoidoscopy 3 years after a negative examination. JAMA 2003; 290: 41-8.
405. Schoenbaum SC. Toward fewer procedures and better outcomes. JAMA 1993; 269: 794-6.
406. Scholten RJ, Devillé WL, Opstelten W, et al. The accuracy of physical diagnostic tests for assessing meniscal lesions of the knee: a metaanalysis. J Fam Pract 2001; 50: 938-44.
407. Schulman KA, Seils DM, Timbie JW, et al. A national survey of provisions in clinical trial agreements between medical schools and industry sponsors. N Engl J Med 2002; 347: 1335-41.
408. Schwartz LM, Woloshin S. News media coverage of screening mammography for women in their 40s and tamoxifen for primary prevention of breast cancer. JAMA 2002; 287: 3136-42.
409. Sharp PC, Michielutte R, Freimanis R, et al. Reported pain following mammography screening. Arch Intern Med 2003; 163: 833-6.
410. Sharpe M. The report of the Chief Medical Officer's cfs/me working group: what does it say and will it help? Clin Med JRCPL 2002; 2: 427-9.
411. Sheetz MJ, King GL. Molecular understanding of hyperglycemia's adverse effects for diabetic complications. JAMA 2002; 288: 2579-88.
412. Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995; 333: 1301-7.
413. Showalter E. Hystories. New York: Columbia University Press, 1996.
414. Shumaker SA, Legault C, Rapp SR, et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women. JAMA 2003; 289: 2651-62.
415. Silverstein FE, Faich G, Goldstein JL, et al. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis. The class Study: a randomized controlled trial. JAMA 2000; 284: 1247-55.
416. Simon GE, VonKorff M, Piccinelli M, Fullerton C, Ormel J. An international study of the relation between somatic symptoms and depression. N Engl J Med 1999; 341: 1329-35.
417. Simon JB. Should all people over the age of 50 have regular fecal occult blood tests? (con); Fletcher R. If it works, why not do it? (pro). N Engl J Med 1998; 338: 1151-5.
418. Sloan RP, Bagiella E, VandeCreek L, et al. Should physicians prescribe religious activities? N Engl J Med 2000; 342: 1913-6.
419. Smidt N, van der Windt DA, Assendelft WJ, et al. Corticosteroid injections, physiotherapy or wait-and-see policy for lateral epicondylitis: a randomized controlled trial. Lancet 2002; 359: 657-62.
420. Smith BL. Approaches to breast-cancer staging. N Engl J Med 2000; 342: 580-1.
421. Solomon CG, Dluhy RG. Rethinking postmenopausal hormone therapy. N Engl J Med 2003; 348: 579-80.
422. Sonnenberg A, Delcò F, Inadomi JM. Cost-effectiveness of colonoscopy in screening for colorectal cancer. Ann Intern Med 2000; 133: 547-9.
423. Sox H. Practice guidelines: 1994. Am J Med 1994; 97: 205-7.
424. Sox H. Screening mammography for younger women: back to basics. Ann Intern Med 2002; 137: 361-2.
425. Spiegel BMR, Targownik L, Dulai GS, Garlnek IM. The cost-effectiveness of cyclooxygenase-2 selective inhibitors in the management of chronic arthritis. Ann Intern Med 2003; 138: 795-806.
426. Spitzer WO, LeBlanc F, Dupuis M, et al. Scientific approach to the assessment and management of activity-related spinal disorders. Spine 1987; 12 (7S): S1-S59.
427. Stadtmauer EA, O'Neill A, Goldstein LJ, et al. Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. N Engl J Med 2000; 342: 1069-76.
428. Starr P. The Social Transformation of American Medicine. New York: Basic Books, 1982: 96-109.
429. Steineck G, Helgesen F, Adolfsson J, et al. Quality of life after radical prostatectomy or watchful waiting. N Engl J Med 2002; 347: 790-6.
430. Stelfax HT, Chua G, O'Rourke K, Detsky AS. Conflict of interest in the debate over calcium channel antagonists. N Engl J Med 1998; 338: 101-6.
431. Stone J, Wojcik W, Durrance D, et al. What should we say to patients with symptoms unexplained by disease? the "number needed to offend." BMJ 2002; 325: 1449-50.
432. Strand V, Hochberg MC. The risk of cardiovascular thrombotic events with selective cyclooxygenase-2 inhibitors. Arthritis Rheum 2002; 47: 349-55.
433. Stratton IM, Adler AI, Neil AW, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (ukpds 35): prospective observational study. BMJ 2000; 321: 405-12.
434. Straus SE. Herbal medicines-what's in the bottle? N Engl J Med 2002; 347: 1997-8.
435. Sullivan PF, Smith W, Buchwald D. Latent class analysis of symptoms associated with chronic fatigue syndrome and fibromyalgia. Psychol Med 2002; 32: 881-8.
436. Sutkowski PA, Kannel WB, D'Agostino RB. Changes in risk factors and the decline in mortality from cardiovascular disease. N Engl J Med 1990; 322: 1635-41.
437. Szapary PO, Wolfe ML, Bloedon LT, et al. Guggulipid for the treatment of hypercholesterolemia. JAMA 2003; 290: 765-72.
438. Temple R. Are surrogate markers adequate to assess cardiovascular disease drugs? JAMA 1999; 282: 790-5.
439. Thompson IM, Goodman PF, Tangen CM, et al. The influence of finasteride on the development of prostate cancer. N Engl J Med 2003; 349: 215-24.
440. Thompson PD, Clarkson P, Karas RH. Statin-associated myopathy. JAMA 2003; 289: 1681-90.
441. Thornton H, Dixon-Woods M. Prostate specific antigen testing for prostate cancer. BMJ 2002; 325: 725-6.
442. Thurfjell E. Breast density and the risk of breast cancer. N Engl J Med 2002; 347: 866.
443. Tice JA, Ettinger B, Ensrud K, Wallace R, Blackwell T, Cummings SR. Phytoestrogen supplements for the treatment of hot flashes: the isoflavone clover extract (ice) study. JAMA 2003; 290: 207-14.
444. Towler B, Irwig L, Glasziou P, et al. A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, Hemoccult. BMJ 1998; 317: 559-65.
445. Trichopoulou A, Costacou T, Bamia C, Trichopoulos D. Adherence to a Mediterranean diet and survival in a Greek population. N Engl J Med 2003; 348: 2599-608.
446. Trivedi DP, Doll R, Khaw KT. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomized double blind controlled trial. BMJ 2003; 326: 455-69.
447. Tuomilehto J, Lindström J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343-50.
448. Tuomilehto J, Rastenyte D, Birkenhäger WH, et al. Effects of calciumchannel blockade in older patients with diabetes and systolic hypertension. N Engl J Med 1999; 340: 677-84.
449. Turk D. Clinical effectiveness and cost-effectiveness of treatments for patients with chronic pain. Clin J Pain 2002; 18: 355-65.
450. Turner RB. Echinacea for the common cold: can alternative medicine be evidence-based medicine? Ann Intern Med 2002; 137: 1001-2.
451. UKCCCR DCIS Working Party. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the uk, Australia, and New Zealand: randomized controlled trial. Lancet 2003; 362: 95-102.
452. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (ukpds33). Lancet 1998; 352: 837-53.
453. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (ukpds 38). BMJ 1998; 317: 703-13.
454. University Group Diabetes Program (UGDP). A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. Diabetes 1976; 25: 1129-53.
455. Urwin M, Symmons D, Allison T, et al. Estimating the burden of musculoskeletal disorders in the community: the comparative prevalence of symptoms at different anatomical sites, and the relation to social deprivation. Ann Rheum Dis 1998; 57: 649-55.
456. US Preventive Services Task Force. Postmenopausal hormone replacement therapy for primary prevention of chronic conditions: recommendations and rationale. Ann Intern Med 2002; 137: 834-9.
457. US Preventive Services Task Force. Screening for breast cancer: recommendations and rationale. Ann Intern Med 2002; 137: 344-6.
458. US Preventive Services Task Force. Screening for colorectal cancer: recommendation and rationale. Ann Intern Med 2002; 137: 129-41.
459. US Preventive Services Task Force. Screening for osteoporosis in postmenopausal women: recommendations and rationale. Ann Intern Med 2002; 137: 526-8.
460. US Preventive Services Task Force. Routine vitamin supplementation to prevent cancer and cardiovascular disease: recommendations and rationale. Ann Intern Med 2003; 139: 51-55.
461. Vahtera J, Kivimäkl M, Pentti J. Effect of organisational downsizing on health of employees. Lancet 1997; 350: 1124-8.
462. Vandenbroucke JP, de Craen AJM. Alternative medicine: a "mirror image" for scientific reasoning in conventional medicine. Ann Intern Med 2001; 135: 507-13.
463. Van Tulder MW, Cherkin DC, Berman B, et al. The effectiveness of acupuncture in the management of acute and chronic low back pain: a systematic review within the framework of the Cochrane Collaboration Back Review Group. Spine 1999; 24: 1113-23.
464. Van Tulder MW, Koes BW, Bouter LM. Conservative treatment of acute and chronic low back pain: a systematic review of randomized controlled trials of the most common interventions. Spine 1997; 22: 2128-56.
465. Van Tulder MW, Malmivaara A, Esmail R, Koes B. Exercise therapy for low back pain. Spine 2000; 25: 2784-96.
466. Van Tulder MW, Scholten RJPM, Koes BW, Deyo RA. Nonsteroidal antiinflammatory drugs for low back pain. Spine 2000; 25: 2501-13.
467. Varnauskas E and the European Coronary Surgery Study Group. Twelve-year follow-up of survival in the randomized European coronary surgery study. N Engl J Med 1988; 319: 332-7.
468. Vastag B. Study concludes that moderate psa levels are unrelated to prostate cancer outcomes. JAMA 2002; 287: 969-70.
469. Vercoulen JHMM, Swanink CMA, Fennis JFM, et al. Prognosis in chronic fatigue syndrome: a prospective study on the natural course. Journal of Neurology, Neurosurgery and Psychiatry 1996; 60: 489-494.
470. Verghese J, Lipton RB, Katz MJ, et al. Leisure activities and the risk of dementia in the elderly. JAMA 2003; 348: 2508-16.
471. Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002; 347: 1227-32.
472. Veterans Administration Coronary Artery Bypass Surgery Cooperative Study Group. Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina. N Engl J Med 1984; 311: 1333-9.
473. Vickers AJ, Fisher P, Smith C, et al. Homoeopathy for delayed onset muscle soreness: a randomized double blind placebo controlled trial. Br J Sports Med 1997; 31: 304-7.
474. Wallace RB. Bone health in nursing home residents. JAMA 2000; 284: 1018-9.
475. Walsh JME, Terdiman JP. Colorectal cancer screening. JAMA 2003; 289: 1288-96.
476. Walsh PC. Surgery and the reduction of mortality from prostate cancer. N Engl J Med 2002; 347: 839-40.
477. Wardwell WI. Chiropractors: evolution to acceptance. In: Gevitz N, ed. Other Healers: Unorthodox Medicine in America. Baltimore: Johns Hopkins University Press, 1988: 157-91.
478. Wassertheil-Smoller S, Hendrix SL, Limacher M, et al. Effect of estrogen plus progestin on stroke in postmenopausal women. JAMA 2003; 289: 2673-84.
479. Wazana A. Physicians and the pharmaceutical industry: is a gift ever a gift? JAMA 2000; 283: 373-80.
480. Weinsier RL, Krumdieck CL. Dairy foods and bone health: examination of the evidence. Am J Clin Nutrition 2000; 72: 681-9.
481. Whelton PK, Appel LJ, Espeland MA, et al. Sodium reduction and weight loss in the treatment of hypertension in older persons. JAMA 1998; 279: 839-46.
482. White KP, Østbye T, Harth M, et al. Perspectives on posttraumatic fibromyalgia: a random survey of Canadian general practitioners, orthopedists, physiatrists, and rheumatologists. J Rheumatol 2000; 27: 790-6.
483. Whiting P, Bagnall AM, Sowden AJ, et al. Interventions for the treatment and management of chronic fatigue syndrome: a systematic review. JAMA 2001; 286: 1360-8.
484. Wilkinson R. Unhealthy Societies. London: Routledge, 1996.
485. Willett WC, Stampfer MJ, Manson JE, et al. Coffee consumption and coronary heart disease in women: a ten-year follow-up. JAMA 1996; 275: 458-62.
486. Williams DA, Cary MA, Groner KH, et al. Improving physical functional status in patients with fibromyalgia: a brief cognitive behavioral intervention. J Rheumatol 2002; 29: 1280-6.
487. Wilson A, Hickie I, Lloyd A, et al. Longitudinal study of outcome of chronic fatigue syndrome. BMJ 1994; 308: 756-9.
488. Wilt TJ, Ishani A, Stark G, et al. Saw palmetto extracts for treatment of benign prostatic hyperplasia: a systematic review. JAMA 1998; 280: 1604-9.
489. Wolfe SM. Direct-to-consumer advertising-education or emotion promotion? N Engl J Med 2002; 346: 524-6.
490. Wolk A, Manson JE, Stampfer MJ, et al. Long-term intake of dietary fiber and decreased risk of coronary heart disease among women. JAMA 1999; 281: 1998-2004.
491. Wolsko PM, Eisenberg DM, Davis RB, et al. Patterns and perceptions of care for treatment of back and neck pain. Spine 2003; 28: 292-8.
492. Woodson G. Dual X-ray absorptiometry T-score concordance and discordance between the hip and spine measurement sites. J Clin Densitometry 2000; 3: 319-24.
493. Woolf SH, Lawrence RS. Preserving scientific debate and patient choice: lessons for the consensus panel on mammography screening. JAMA 1997; 278: 2105-8.
494. Woolhandler S, Campbell T, Himmelstein DU. Costs of health care administration in the United States and Canada. N Engl J Med 2003; 349: 768-75.
495. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 2002; 288: 321-3.